drugset / Trial / NCT01131858

Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency

NCT01131858

Phase 1/2 Completed 140 enrolled Karolinska University Hospital
RandomizedSingle-groupQuadruple-blindPrevention

Summary

Hypothesis: Cholecalciferol (vitamin D3) prevent respiratory tract infections in patients with primary immunodeficiency.

Timeline

Start
2010-03
Primary completion
2011-06
Completion
2011-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 4000 iu